DE60003045D1 - Heterozyclische verbindungen als angiogenese inhibitoren - Google Patents

Heterozyclische verbindungen als angiogenese inhibitoren

Info

Publication number
DE60003045D1
DE60003045D1 DE60003045T DE60003045T DE60003045D1 DE 60003045 D1 DE60003045 D1 DE 60003045D1 DE 60003045 T DE60003045 T DE 60003045T DE 60003045 T DE60003045 T DE 60003045T DE 60003045 D1 DE60003045 D1 DE 60003045D1
Authority
DE
Germany
Prior art keywords
heterocyclic compounds
angiogenesis inhibitors
angiogenesis
inhibitors
heterocyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60003045T
Other languages
English (en)
Other versions
DE60003045T2 (de
Inventor
Nandor Makk
Gabor Ambrus
Aniketa Tegdes
Andras Jeney
Ferenc Timar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva Hungary Pharmaceutical Marketing PLC
Original Assignee
Institute for Drugs Research Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute for Drugs Research Ltd filed Critical Institute for Drugs Research Ltd
Application granted granted Critical
Publication of DE60003045D1 publication Critical patent/DE60003045D1/de
Publication of DE60003045T2 publication Critical patent/DE60003045T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
DE60003045T 1999-08-02 2000-08-02 Heterozyclische verbindungen als angiogenese inhibitoren Expired - Fee Related DE60003045T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HU9902628A HUP9902628A3 (en) 1999-08-02 1999-08-02 Angiogenesis inhibiting borrelidin derivatives, their use and pharmaceutical compositions containing them
HU9902628P 1999-08-02
PCT/HU2000/000088 WO2001009113A2 (en) 1999-08-02 2000-08-02 Heterocyclic compounds inhibiting angiogenesis

Publications (2)

Publication Number Publication Date
DE60003045D1 true DE60003045D1 (de) 2003-07-03
DE60003045T2 DE60003045T2 (de) 2004-04-01

Family

ID=89998954

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60003045T Expired - Fee Related DE60003045T2 (de) 1999-08-02 2000-08-02 Heterozyclische verbindungen als angiogenese inhibitoren

Country Status (32)

Country Link
US (1) US6815465B1 (de)
EP (1) EP1206462B1 (de)
JP (1) JP2003506366A (de)
KR (1) KR20020068495A (de)
CN (1) CN1243746C (de)
AP (1) AP1383A (de)
AT (1) ATE241611T1 (de)
AU (1) AU772206B2 (de)
BG (1) BG106373A (de)
BR (1) BR0012968A (de)
CA (1) CA2378176A1 (de)
CZ (1) CZ2002405A3 (de)
DE (1) DE60003045T2 (de)
DK (1) DK1206462T3 (de)
ES (1) ES2200900T3 (de)
HK (1) HK1048995B (de)
HR (1) HRP20020103B1 (de)
HU (1) HUP9902628A3 (de)
IL (1) IL147904A (de)
IS (1) IS2137B (de)
MX (1) MXPA02001117A (de)
NO (1) NO20020485L (de)
NZ (1) NZ517422A (de)
OA (1) OA12004A (de)
PL (1) PL354281A1 (de)
PT (1) PT1206462E (de)
RU (1) RU2247723C2 (de)
SK (1) SK1822002A3 (de)
UA (1) UA74341C2 (de)
WO (1) WO2001009113A2 (de)
YU (1) YU7302A (de)
ZA (1) ZA200200838B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6693099B2 (en) * 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
ATE452896T1 (de) 2002-03-12 2010-01-15 Bristol Myers Squibb Co C3-cyanoepothilonderivate
GB0230217D0 (en) * 2002-12-27 2003-02-05 Biotica Tech Ltd Borrelidin-producing polyketide synthase and its uses
US8440217B1 (en) 2005-06-15 2013-05-14 Mawaheb M. EL-Naggar Method and system with contact lens product for treating and preventing adverse eye conditions
GB0609981D0 (en) * 2006-05-19 2006-06-28 Biotica Tech Ltd Novel compounds
GB0713563D0 (en) * 2007-07-13 2007-08-22 Biotica Tech Ltd Methods of screening for anti-angiogenic compounds
MX2010001462A (es) * 2007-08-27 2010-03-01 Basf Se Compuestos de pirazol para controlar plagas de invertebrados.
DE102008014077A1 (de) 2008-03-13 2009-09-17 Discovery Partner International Gmbh Borrelidin-Derivate
WO2009141786A2 (en) * 2008-05-21 2009-11-26 Piramal Life Sciences Limited Anti-inflammatory compounds
EP3492499A1 (de) 2014-12-15 2019-06-05 Borealis AG Schmelzgeblasene bahnen ohne schüsse und mit verbesserten barriereeigenschaften

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08173176A (ja) * 1994-12-22 1996-07-09 Mercian Corp 血管新生阻害剤
JP3786461B2 (ja) * 1996-02-22 2006-06-14 メルシャン株式会社 新生理活性物質

Also Published As

Publication number Publication date
NO20020485L (no) 2002-03-21
PL354281A1 (en) 2003-12-29
RU2247723C2 (ru) 2005-03-10
HUP9902628A3 (en) 2001-07-30
HRP20020103B1 (en) 2005-06-30
PT1206462E (pt) 2003-10-31
YU7302A (sh) 2004-09-03
CN1243746C (zh) 2006-03-01
AU6309000A (en) 2001-02-19
ES2200900T3 (es) 2004-03-16
MXPA02001117A (es) 2003-08-20
HUP9902628A2 (hu) 2001-05-28
BG106373A (en) 2002-09-30
DK1206462T3 (da) 2003-09-29
WO2001009113A3 (en) 2001-06-14
IS6258A (is) 2002-02-01
AP2002002413A0 (en) 2002-03-31
NZ517422A (en) 2005-02-25
US6815465B1 (en) 2004-11-09
KR20020068495A (ko) 2002-08-27
DE60003045T2 (de) 2004-04-01
ZA200200838B (en) 2003-08-27
IL147904A0 (en) 2002-08-14
AP1383A (en) 2005-04-05
EP1206462B1 (de) 2003-05-28
CZ2002405A3 (cs) 2002-07-17
CN1372556A (zh) 2002-10-02
JP2003506366A (ja) 2003-02-18
ATE241611T1 (de) 2003-06-15
EP1206462A2 (de) 2002-05-22
HK1048995B (zh) 2006-07-21
HU9902628D0 (en) 1999-10-28
AU772206B2 (en) 2004-04-22
IL147904A (en) 2005-09-25
HRP20020103A2 (en) 2004-02-29
CA2378176A1 (en) 2001-02-08
UA74341C2 (uk) 2005-12-15
WO2001009113A2 (en) 2001-02-08
OA12004A (en) 2006-04-18
NO20020485D0 (no) 2002-01-30
BR0012968A (pt) 2002-05-14
IS2137B (is) 2006-08-14
HK1048995A1 (en) 2003-04-25
SK1822002A3 (en) 2002-08-06

Similar Documents

Publication Publication Date Title
DE60012031D1 (de) Piperazin verbindungen als tachykinin-antagonisten
DE69905582D1 (de) Heterocyclische verbindungen als rotamase-enzymen inhibitoren
ATE299507T1 (de) Bizyklische heteroaromatische verbindungen als lh-agonisten
DE60112064D1 (de) Benzoamid-piperidin verbindungen als substanz p-antagonisten
ATE437862T1 (de) Pyrimidin-5-onderivate als ldl-pla2 inhibitoren
ATE330954T1 (de) Quinazolin-derivate als vegf-hemmer
DE60032601D1 (de) Als antikrebsmittel verwendbare heterocyklische derivate
DE60003702D1 (de) Heterocyclische verbindungen als reversible inhibitoren von cysteinproteasen
ATE256127T1 (de) Betacarbolinderivate als phosphodiesterase- inhibitoren
ITMI992711A0 (it) Composti organici
ATE286036T1 (de) Heteroaromatische alkynylphenyl-verbindungen als glukokinase-aktivatoren
ATE278690T1 (de) Substituierte pyprolopyridinonderivate als phosphodiesterase-inhibitoren
ATE291575T1 (de) N-carbamoyloxyalkyl-substituierte azolium- verbindungen
ATE248836T1 (de) Heterozyklische verbindungen als inhibitoren der rotamaseaktivität
DE60008524D1 (de) Furanonderivate als inhibitoren von cathepsin s
ATE236157T1 (de) Imidazopyridinderivate als phosphodiesterase vii- hemmer
NO20023013L (no) Substituerte 8-arylkinolin-fosfodiesterase-4-inhibitorer
ATE245653T1 (de) Imidazolverbindungen als phosphodiesterase vii- hemmer
ATE428420T1 (de) Substituierte 8-arylchinoline als phosphodiesterase-4-hemmer
DE60003045D1 (de) Heterozyclische verbindungen als angiogenese inhibitoren
ATE529419T1 (de) Chromanderivate als estrogene verbindungen
ATE300945T1 (de) Isoxazolderivate als phosphodiesterase vii-hemmer
NO20025659L (no) Heterocykliske forbindelser
DE60003072D1 (de) Thiazolidindion-derivate als antidiabetika
ATE247121T1 (de) Imidazolderivate als phosphodiesterase vii-hemmer

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: IVAX DRUG RESEARCH INSTITUTE LTD., BUDAPEST, HU

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee